Cardiac Rhythm Management Devices Market Snapshot

Published October 2023 | 10 Pages | 5 Exhibits | Forecasts Through 2027

snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Overview

This market snapshot from Life Science Intelligence provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore the natural rhythm and function of the heart that can be impaired as a result of cardiac rhythm disorders and heart failure.  

This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into:

  • Unit volumes from 2022 to 2027
  • Market forecasts from 2022 to 2027
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

Abbott
AtaCor Medical
BioTrace Medical
Biotronik
Boston Scientific
Cairdac
Electroducer
FineHeart
Lepu medical
LivaNova
Medico
Medtronic
Merit Medical
Microport Scientific
Osypka Medical
Pacetronix

Ready to get started?

We help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.